Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Antibiotic Selection

Antibiotic Selection

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The vascular contribution to immunotherapy success.

Angiogenesis·2026

Same author

Modeling CAF-tumor interactions to overcome therapy resistance.

Journal of experimental & clinical cancer research : CR·2026

Same author

Leveraging multi-organ models for drug combination therapy safety.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Same author

Dynamical memory underlies prolonged plasmid persistence after transient antibiotic treatment.

bioRxiv : the preprint server for biology·2025

Same author

Death never dies: increasing impact of programmed cell death.

Apoptosis : an international journal on programmed cell death·2025

Same author

Rational Design of Non-Toxic Multidrug Combinations Demonstrates Durable and Hypoxia-Enhanced Efficacy Against Renal Cell Carcinoma.

Pharmaceutics·2025

Same journal

From the Editor-in-Chief: The 2013 JALA Ten: Call for Nominations.

Journal of laboratory automation·2017

Same journal

From the Editor-in-Chief: The JALA Special Issues on Robotics in Laboratory Automation.

Journal of laboratory automation·2017

Same journal

Informatics and Computing.

Journal of laboratory automation·2017

Same journal

Informatics and Computing.

Journal of laboratory automation·2017

Same journal

Automated Systems.

Journal of laboratory automation·2017

Same journal

Lab Automation Services.

Journal of laboratory automation·2017

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Current Trends in Multidrug Optimization.

Andrea Weiss¹, Patrycja Nowak-Sliwinska²

¹1 Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.

Journal of Laboratory Automation

|January 18, 2017

Summary

This summary is machine-generated.

Optimizing cancer drug combinations is complex. This review explores advanced heuristic optimization techniques and phenotype-based screening to identify effective cancer therapies, overcoming drug resistance and toxicity.

Keywords:

drug mixture optimization drug–drug interactions feedback system control response surface synergistic drug combinations top-down approach

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Related Experiment Videos

Last Updated: Mar 8, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Area of Science:

Oncology
Computational Biology
Pharmacology

Background:

Cancer therapy faces challenges like patient heterogeneity, drug resistance, and toxicity.
Drug combinations offer potential to overcome limitations by targeting biological robustness and redundancy.
Optimizing drug combinations is complex, requiring advanced heuristic optimization techniques.

Purpose of the Study:

To review optimization techniques for identifying optimal cancer drug combinations.
To focus on phenotype-based screening approaches in cancer therapy.
To critically discuss the advantages, disadvantages, and limitations of these methods.

Main Methods:

Discussion of modeling methods for drug combination optimization.
Exploration of model-free approaches using biological search algorithms.
Analysis of merged approaches, including network biology and computational models using phenotypic data.

Main Results:

Phenotype-based screening offers diverse approaches for drug combination optimization.
Modeling, model-free, and merged methods present distinct advantages and disadvantages.
Successful application requires careful consideration of limitations in biological research.

Conclusions:

Advanced optimization techniques are crucial for effective cancer drug combination identification.
Phenotype-based screening, particularly network biology, shows promise.
Understanding method limitations is key for successful implementation in cancer therapy research.